A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof

Details for Australian Patent Application No. 2001289813 (hide)

Owner Intercell AG

Inventors Egyed, Alena; Buschle, Michael; Zauner, Wolfgang; Mattner, Frank; Fritz, Jorg

Agent Wrays

Pub. Number AU-B-2001289813

PCT Pub. Number WO02/13857

Priority 1416/2000 17.08.00 AT

Filing date 17 August 2001

Wipo publication date 16 July 2002

Acceptance publication date 28 July 2005

International Classifications

A61K 039/39 Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

Event Publications

15 January 2004 Change of Name(s) of Applicant(s), Section 104

  Intercell Biomedizinische Forschungs-Und Entwicklungs AG The name of the applicant has been changed to Intercell AG

28 July 2005 Application Accepted

  Published as AU-B-2001289813

24 November 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001289814

2001289812-METHOD, NETWORK ELEMENT, AND TERMINAL DEVICE FOR MARKING DATA PACKETS